Table 1.
Clinical and laboratory features of groups
| Patient | Control | |||
| n | % | n | % | |
| Gender Female | 20 | 87.0 | 20 | 95.5 |
| Male | 3 | 13.0 | 1 | 4.5 |
| BMI Normal weight | 6 | 26.1 | ||
| Overweight | 7 | 30.4 | ||
| Obese | 9 | 39.1 | ||
| Morbidly obese | 1 | 4.3 | ||
| Mean±STD | Median | Mean±STD | Median | |
| Age (year) | 56.1±6.6 | 56 | 36.3±7.5 | 35 |
| Glucose (mg/dL) | 154.5±55.2 | 133 | 85.9±10.1 | 84 |
| HBA1c (%) | 7.5±1.5 | 6.95 | 5.5±0.6 | 5.5 |
| T-chol (mg/dL) | 222.4±59.3 | 217 | 176.6±29.9 | 178 |
| Triglyceride (mg/dL) | 192.6±146.9 | 142 | 86.6±45.9 | 82 |
| HDL-chol (mg/dL) | 46.2±12.5 | 45 | 54.3±13.1 | 55 |
| LDL-chol (mg/dL) | 142.9±48.4 | 138.8 | 105.0±27.4 | 103.2 |
| CRP (mg/L) | 7.6±9.8 | 5.5 | 4.3±10.4 | 0.8 |
| Insulin (u/dL) | 9.2±4.4 | 9.8 | 5.4±2.6 | 4.8 |
| Adiponectin (ng/mL) | 9.3±2.7 | 9.6 | 11.6±3.4 | 12.0 |
(BMI: Body mass index, CRP: C reactive protein, chol: cholesterol).